[New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds
Un nuovo ipoglicemizzante orale: K 4024 o glipizide. Sperimentazione clinica.